Benzinga | Aug 6, 2020 10:13AM EDT

Stifel Maintains Buy on Global Blood Therapeutics, Raises Price Target to $118

Stifel maintains Global Blood Therapeutics (NASDAQ:GBT) with a Buy and raises the price target from $113 to $118.